CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.

Lorusso, V

CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group. [electronic resource] - International journal of oncology Jan 2000 - 149-54 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1019-6439

10.3892/ijo.16.1.149 doi


Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bleomycin--administration & dosage
Cyclophosphamide--administration & dosage
Cytarabine--administration & dosage
Doxorubicin--administration & dosage
Epirubicin--administration & dosage
Etoposide--administration & dosage
Female
Humans
Lymphoma, Non-Hodgkin--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Neoplasm Staging
Prednisone--administration & dosage
Survival Analysis
Treatment Outcome
Vincristine--administration & dosage